| scholarly article | Q13442814 |
| P2093 | author name string | W. Wang | |
| H. Zhang | |||
| F. Jiang | |||
| S. W. Cheung | |||
| M. K. Chan | |||
| A. N. Pursley | |||
| H. Y. C. Chan | |||
| K. W. Choy | |||
| L. F. J. Jong | |||
| O. K. C. Yuen | |||
| P. S. S. Lo | |||
| T. K. Lau | |||
| W. S. K. Chan | |||
| P2860 | cites work | Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci | Q24632266 |
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies | Q34496747 | ||
| Is the prevalence of Klinefelter syndrome increasing? | Q34713434 | ||
| Next-generation sequencing transforms today's biology | Q34731728 | ||
| Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities | Q35856339 | ||
| Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience. | Q36353229 | ||
| Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma | Q36595101 | ||
| Genetic considerations in the patient with Turner syndrome--45,X with or without mosaicism | Q36613437 | ||
| Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples | Q37004989 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
| Decision to abort after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature | Q37975107 | ||
| Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
| Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism | Q43073795 | ||
| Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. | Q43418239 | ||
| A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing | Q45049473 | ||
| Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma | Q46170290 | ||
| Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies | Q46405224 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing | Q46816545 | ||
| Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown cause. | Q52010641 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service | Q58028956 | ||
| Non-invasive prenatal screening of fetal sex chromosomal abnormalities: perspective of pregnant women | Q58028979 | ||
| Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype | Q58029039 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | whole genome sequencing | Q2068526 |
| P304 | page(s) | 254-64 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | |
| P478 | volume | 43 |
| Q39160177 | A population-based study of prevalence of Down syndrome in Southern Thailand |
| Q97419367 | A rare Down syndrome foetus with de novo 21q;21q rearrangements causing false negative results in non-invasive prenatal testing: a case report |
| Q28072788 | Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis |
| Q35552815 | Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis |
| Q36173927 | Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis |
| Q38889509 | Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy |
| Q56518082 | Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform |
| Q33578615 | Aneuploidy screening by non-invasive prenatal testing in twin pregnancy |
| Q31011773 | Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13. |
| Q48150119 | Author's reply to Grati and Benn |
| Q38830153 | Benefits and limitations of prenatal screening for Prader-Willi syndrome |
| Q42393162 | Cell-free fetal DNA: the new tool in fetal medicine |
| Q38418240 | Clinical implementation of NIPT - technical and biological challenges |
| Q44733231 | Clinical implementation of cell-free DNA-based aneuploidy screening: perspectives from a national audit |
| Q43143925 | Combined first trimester screen or noninvasive prenatal testing or both |
| Q36003623 | Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy |
| Q40459322 | Contingent non-invasive prenatal testing: an opportunity to improve non-genetic aspects of fetal aneuploidy screening. |
| Q48282895 | Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing. |
| Q30643919 | Copy-number variation and false positive prenatal aneuploidy screening results |
| Q36656349 | False Negative Cell-Free DNA Screening Result in a Newborn with Trisomy 13. |
| Q36461785 | Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb |
| Q38562550 | Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q48352229 | Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome? |
| Q39764849 | Identification of minor chromosomal defects causing abnormal foetus and spontaneous abortions |
| Q40457184 | Karyotype analysis with amniotic fluid in 12365 pregnant women with indications for genetic amniocentesis and strategies of prenatal diagnosis. |
| Q57809529 | Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals |
| Q37472073 | NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results |
| Q41566460 | Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. |
| Q64969403 | Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies. |
| Q92982636 | Noninvasive Prenatal Testing - When Is It Advantageous to Apply |
| Q40220994 | Noninvasive fetal trisomy detection by multiplexed semiconductor sequencing: a barcoding analysis strategy. |
| Q51343352 | Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center. |
| Q37354838 | Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center |
| Q27324761 | Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management |
| Q36007458 | Practicability of prenatal testing using lectin-based enrichment of fetal erythroblasts |
| Q90259969 | Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing |
| Q38601652 | Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease |
| Q50058086 | Screening for fetal chromosomal and subchromosomal disorders |
| Q34295095 | Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre |
| Q36245906 | Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number Variation |
| Q38661271 | Systematic review and meta-analysis of non-invasive prenatal DNA testing for trisomy 21: implications for implementation in China |
| Q59795817 | The application of NIPT using combinatorial probe-anchor synthesis to identify sex chromosomal aneuploidies (SCAs) in a cohort of 570 pregnancies |
| Q34374066 | The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform |
| Q38760100 | The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon |
| Q39641895 | Validation of combinatorial probe-anchor ligation-based sequencing as non-invasive prenatal test for trisomy at a central laboratory |
| Q30151607 | Views of American OB/GYNs on the ethics of prenatal whole-genome sequencing |
| Q48169164 | Views of the obstetric profession on non-invasive prenatal testing in Aotearoa New Zealand: A national survey |
Search more.